<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Island Pharmaceuticals Ltd — News on 6ix</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd</link>
<description>Latest news and press releases for Island Pharmaceuticals Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 09 Mar 2026 03:08:03 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/island-pharmaceuticals-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683666dc78dffbe2df15e1b6.webp</url>
<title>Island Pharmaceuticals Ltd</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd</link>
</image>
<item>
<title>Antiviral pipeline expansion through strategic collaboration</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/antiviral-pipeline-expansion-through-strategic-collaboration</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/antiviral-pipeline-expansion-through-strategic-collaboration</guid>
<pubDate>Mon, 09 Mar 2026 03:08:03 GMT</pubDate>
<description>Antiviral pipeline expansion through strategic collaboration</description>
</item>
<item>
<title>US Government collaboration for Galidesivir development</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/us-government-collaboration-for-galidesivir-development</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/us-government-collaboration-for-galidesivir-development</guid>
<pubDate>Wed, 04 Mar 2026 03:43:18 GMT</pubDate>
<description>US Government collaboration for Galidesivir development</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/trading-halt-514</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/trading-halt-514</guid>
<pubDate>Mon, 02 Mar 2026 03:58:14 GMT</pubDate>
<description>Trading Halt</description>
</item>
<item>
<title>Appendix 4D & Half-Year Financial Statements</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/appendix-4d-and-half-year-financial-statements-11</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/appendix-4d-and-half-year-financial-statements-11</guid>
<pubDate>Wed, 25 Feb 2026 10:42:04 GMT</pubDate>
<description>Appendix 4D & Half-Year Financial Statements</description>
</item>
<item>
<title>Response to ASX Query Letter</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/response-to-asx-query-letter-31</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/response-to-asx-query-letter-31</guid>
<pubDate>Tue, 10 Feb 2026 05:06:03 GMT</pubDate>
<description>Response to ASX Query Letter</description>
</item>
<item>
<title>$9m placement to advance US biodefence opportunity</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/dollar9m-placement-to-advance-us-biodefence-opportunity</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/dollar9m-placement-to-advance-us-biodefence-opportunity</guid>
<pubDate>Wed, 04 Feb 2026 03:55:05 GMT</pubDate>
<description>$9m placement to advance US biodefence opportunity</description>
</item>
<item>
<title>FDA confirms Galidesivir approval pathway</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/fda-confirms-galidesivir-approval-pathway</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/fda-confirms-galidesivir-approval-pathway</guid>
<pubDate>Wed, 04 Feb 2026 03:50:06 GMT</pubDate>
<description>FDA confirms Galidesivir approval pathway</description>
</item>
<item>
<title>Quarterly Appendix 4C and Activities Report</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/quarterly-appendix-4c-and-activities-report-2</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/quarterly-appendix-4c-and-activities-report-2</guid>
<pubDate>Tue, 27 Jan 2026 02:53:17 GMT</pubDate>
<description>Quarterly Appendix 4C and Activities Report</description>
</item>
<item>
<title>US Patent Granted for Galidesivir in filoviridae viruses</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/us-patent-granted-for-galidesivir-in-filoviridae-viruses</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/us-patent-granted-for-galidesivir-in-filoviridae-viruses</guid>
<pubDate>Wed, 07 Jan 2026 04:05:09 GMT</pubDate>
<description>US Patent Granted for Galidesivir in filoviridae viruses</description>
</item>
<item>
<title>Ongoing engagement with the US FDA</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/ongoing-engagement-with-the-us-fda</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/ongoing-engagement-with-the-us-fda</guid>
<pubDate>Mon, 05 Jan 2026 03:02:04 GMT</pubDate>
<description>Ongoing engagement with the US FDA</description>
</item>
<item>
<title>Agreement with Texas Biomed for Galidesivir Program</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/agreement-with-texas-biomed-for-galidesivir-program</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/agreement-with-texas-biomed-for-galidesivir-program</guid>
<pubDate>Wed, 17 Dec 2025 02:57:05 GMT</pubDate>
<description>Agreement with Texas Biomed for Galidesivir Program</description>
</item>
<item>
<title>Island expands Galidesivir IP with US Patent Grant</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/island-expands-galidesivir-ip-with-us-patent-grant</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/island-expands-galidesivir-ip-with-us-patent-grant</guid>
<pubDate>Fri, 05 Dec 2025 04:13:14 GMT</pubDate>
<description>Island expands Galidesivir IP with US Patent Grant</description>
</item>
<item>
<title>Additional FDA Submission completed for Galidesivir</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/additional-fda-submission-completed-for-galidesivir</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/additional-fda-submission-completed-for-galidesivir</guid>
<pubDate>Thu, 04 Dec 2025 02:48:14 GMT</pubDate>
<description>Additional FDA Submission completed for Galidesivir</description>
</item>
<item>
<title>Options exercised raises $1million</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/options-exercised-raises-dollar1million</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/options-exercised-raises-dollar1million</guid>
<pubDate>Wed, 03 Dec 2025 02:58:14 GMT</pubDate>
<description>Options exercised raises $1million</description>
</item>
<item>
<title>Coalition acceptance to advance US procurement & stockpiling</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/coalition-acceptance-to-advance-us-procurement-and-stockpiling</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/coalition-acceptance-to-advance-us-procurement-and-stockpiling</guid>
<pubDate>Mon, 24 Nov 2025 03:04:15 GMT</pubDate>
<description>Coalition acceptance to advance US procurement & stockpiling</description>
</item>
<item>
<title>Island engages advisers to advance biodefence strategy</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/island-engages-advisers-to-advance-biodefence-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/island-engages-advisers-to-advance-biodefence-strategy</guid>
<pubDate>Thu, 20 Nov 2025 03:54:16 GMT</pubDate>
<description>Island engages advisers to advance biodefence strategy</description>
</item>
<item>
<title>FDA agrees Animal Rule pathway and PRV eligibility</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/fda-agrees-animal-rule-pathway-and-prv-eligibility</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/fda-agrees-animal-rule-pathway-and-prv-eligibility</guid>
<pubDate>Mon, 17 Nov 2025 03:48:22 GMT</pubDate>
<description>FDA agrees Animal Rule pathway and PRV eligibility</description>
</item>
<item>
<title>FDA confirms response timing for Galidesivir</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/fda-confirms-response-timing-for-galidesivir</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/fda-confirms-response-timing-for-galidesivir</guid>
<pubDate>Wed, 22 Oct 2025 02:54:23 GMT</pubDate>
<description>FDA confirms response timing for Galidesivir</description>
</item>
<item>
<title>US FDA Type C meeting briefing document submitted</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/us-fda-type-c-meeting-briefing-document-submitted</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/us-fda-type-c-meeting-briefing-document-submitted</guid>
<pubDate>Mon, 29 Sep 2025 02:50:11 GMT</pubDate>
<description>US FDA Type C meeting briefing document submitted</description>
</item>
<item>
<title>FDA Meeting request granted</title>
<link>https://6ix.com/company/island-pharmaceuticals-ltd/news/fda-meeting-request-granted</link>
<guid isPermaLink="true">https://6ix.com/company/island-pharmaceuticals-ltd/news/fda-meeting-request-granted</guid>
<pubDate>Fri, 19 Sep 2025 03:50:15 GMT</pubDate>
<description>FDA Meeting request granted</description>
</item>
</channel>
</rss>